Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Rhea-AI Summary

Harvard Bioscience, Inc. (Nasdaq: HBIO) announced that Chairman and CEO Jim Green, along with CFO Jennifer Cote, will present at the Southwest IDEAS Investor Conference on November 16, 2023. The presentation will be available for replay on the company's website. One-on-one meetings with investors will also be hosted.

HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining him will be Jennifer Cote, the company’s Chief Financial Officer and Treasurer.

The Company’s presentation will begin at 9:40 AM ET / 8:40 AM CT on November 16^th. A replay of the presentation will be available on the Investor Relations section Harvard Bioscience website shortly after the presentation has concluded.

Harvard Bioscience will also host one-on-one meetings with investors on Thursday, November 16. To register for the conference or to schedule a one-on-one meeting, please visit https://www.threepartadvisors.com/southwest.

About Harvard Bioscience

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Investor Inquiries:

Harvard Bioscience, Inc.
Investor Relations investors@harvardbioscience.com
(508) 893-3120

FAQ

What is the date of the Southwest IDEAS Investor Conference for Harvard Bioscience, Inc. (Nasdaq: HBIO)?

The conference will take place on November 16, 2023.

Who will be presenting at the conference for Harvard Bioscience, Inc. (Nasdaq: HBIO)?

Chairman and CEO Jim Green, along with CFO Jennifer Cote, will be presenting.

Where can investors watch the replay of the presentation for Harvard Bioscience, Inc. (Nasdaq: HBIO)?

The replay will be available on the company's website.

How can investors schedule a one-on-one meeting with Harvard Bioscience, Inc. (Nasdaq: HBIO)?

Investors can register for the conference or schedule a meeting at https://www.threepartadvisors.com/southwest.